• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Pyxis Oncology, Inc. - Common Stock (NQ:PYXS)

2.060 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Jan 12, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Pyxis Oncology, Inc. - Common Stock

< Previous 1 2 Next >
News headline image
The $225B Precision Sprint: How Big Pharma is Beating the $170B Patent Cliff
January 12, 2026
Issued on behalf of Oncolytics Biotech Inc. 
From Equity Insider
Via GlobeNewswire
News headline image
Pyxis Oncology Announces Positive Preliminary Phase 1 Data for Micvotabart Pelidotin (MICVO) in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
December 18, 2025
From Pyxis Oncology
Via GlobeNewswire
News headline image
Pyxis Oncology to Participate in Upcoming Investor Conferences
November 03, 2025
From Pyxis Oncology
Via GlobeNewswire
News headline image
Pyxis Oncology Provides Business Update and Reports Third Quarter 2025 Financial Results
November 03, 2025
From Pyxis Oncology
Via GlobeNewswire
News headline image
Pyxis Oncology to Present Translational Data and Key Biology Findings Elucidating the Mechanism of Action of MICVO at Upcoming Medical Meetings
October 13, 2025
From Pyxis Oncology
Via GlobeNewswire
News headline image
Pyxis Oncology Appoints Alex Kane as Senior Vice President, Investor Relations & Capital Markets
October 09, 2025
From Pyxis Oncology
Via GlobeNewswire
News headline image
Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 30, 2025
From Pyxis Oncology
Via GlobeNewswire
News headline image
Pyxis Oncology to Participate in September Investor and Industry Conferences
August 21, 2025
From Pyxis Oncology
Via GlobeNewswire
News headline image
Pyxis Oncology Reports Second Quarter 2025 Financial Results and Provides Business Update
August 14, 2025
From Pyxis Oncology
Via GlobeNewswire
News headline image
Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 30, 2025
From Pyxis Oncology
Via GlobeNewswire
News headline image
Pyxis Oncology Reports First Quarter 2025 Financial Results and Provides Business Update
May 15, 2025
From Pyxis Oncology
Via GlobeNewswire
News headline image
Pyxis Oncology to Participate in Two Upcoming Investor Conferences
May 14, 2025
From Pyxis Oncology
Via GlobeNewswire
News headline image
Pyxis Oncology Presents Promising Preclinical Results Providing Proof of Mechanism of Micvotabart Pelidotin, the First-in-Concept Extracellular-Targeting ADC
April 25, 2025
From Pyxis Oncology
Via GlobeNewswire
News headline image
Pyxis Oncology to Participate in the Stifel 2025 Virtual Targeted Oncology Forum
April 02, 2025
From Pyxis Oncology
Via GlobeNewswire
News headline image
Pyxis Oncology to Present New Preclinical Data Supporting Development of First-In-Concept ADC Targeting EDB+FN in Tumor Microenvironment at AACR 2025
March 25, 2025
From Pyxis Oncology
Via GlobeNewswire
News headline image
Pyxis Oncology Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
March 18, 2025
From Pyxis Oncology
Via GlobeNewswire
News headline image
Pyxis Oncology to Participate at the Leerink Partners Global Healthcare Conference
March 03, 2025
From Pyxis Oncology
Via GlobeNewswire
News headline image
Pyxis Oncology Granted FDA Fast Track Designation for PYX-201 Monotherapy in Patients with Recurrent or Metastatic Head and Neck Cancer
February 26, 2025
Designation applies to the treatment of adult patients with recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC) whose disease has progressed following treatment with... 
From Pyxis Oncology
Via GlobeNewswire
News headline image
Pyxis Oncology Initiates New PYX-201 Combination Trial and Initiates Cohort Expansions of Ongoing Monotherapy Trial
February 04, 2025
From Pyxis Oncology
Via GlobeNewswire
News headline image
Pyxis Oncology Announces Portfolio Prioritization, Focusing Resources on its Lead Clinical Program, PYX-201
December 19, 2024
From Pyxis Oncology
Via GlobeNewswire
News headline image
Pyxis Oncology Announces Favorable Preliminary PYX-201 Clinical Phase 1 Part 1 Data
November 20, 2024
From Pyxis Oncology
Via GlobeNewswire
News headline image
Pyxis Oncology Provides Corporate Update and Reports Financial Results for Third Quarter 2024
November 12, 2024
From Pyxis Oncology
Via GlobeNewswire
News headline image
Pyxis Oncology to Host In-Person (NYC) and Virtual Investor Event on Wednesday, November 20, 2024, to Present Preliminary Data from the Phase 1 Dose Escalation Trial of PYX-201
November 11, 2024
From Pyxis Oncology
Via GlobeNewswire
News headline image
Pyxis Oncology to Participate in Two Upcoming Investor Conferences
August 29, 2024
From Pyxis Oncology
Via GlobeNewswire
News headline image
Pyxis Oncology Provides Corporate Update and Reports Financial Results for Second Quarter 2024
August 14, 2024
From Pyxis Oncology
Via GlobeNewswire
News headline image
Pyxis Oncology to Participate in the BTIG Virtual Biotechnology Conference
July 29, 2024
From Pyxis Oncology
Via GlobeNewswire
News headline image
Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 28, 2024
From Pyxis Oncology
Via GlobeNewswire
News headline image
Pyxis Oncology Expands Board of Directors with Appointment of Michael A. Metzger
June 10, 2024
From Pyxis Oncology
Via GlobeNewswire
News headline image
Pyxis Oncology to Participate in a Fireside Chat at the Jefferies Global Healthcare Conference
May 30, 2024
From Pyxis Oncology
Via GlobeNewswire
News headline image
Pyxis Oncology Provides Corporate Update and Reports Financial Results for First Quarter 2024
May 14, 2024
From Pyxis Oncology
Via GlobeNewswire
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap